SO
ARCT icon

STRS Ohio’s Arcturus Therapeutics ARCT Stock Holding History

STRS Ohio’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,400
Closed -$89K – 2202
2025
Q1 		$89K Hold
8,400
– – ﹤0.01% 1688
2024
Q4 		$143K Sell
8,400
-4,900
-37% -$92.2K ﹤0.01% 1581
2024
Q3 		$309K Sell
13,300
-4,600
-26% -$98.4K ﹤0.01% 1437
2024
Q2 		$436K Buy
17,900
+1,800
+11% +$54.6K ﹤0.01% 1318
2024
Q1 		$543K Sell
16,100
-9,100
-36% -$322K ﹤0.01% 1199
2023
Q4 		$794K Buy
25,200
+4,000
+19% +$95.1K ﹤0.01% 997
2023
Q3 		$541K Sell
21,200
-2,700
-11% -$83.2K ﹤0.01% 1212
2023
Q2 		$685K Buy
+23,900
New +$651K ﹤0.01% 1101
2022
Q4 		– Sell
-4,300
Closed -$63K – 1979
2022
Q3 		$63K Hold
4,300
– – ﹤0.01% 1811
2022
Q2 		$67K Hold
4,300
– – ﹤0.01% 1822
2022
Q1 		$115K Hold
4,300
– – ﹤0.01% 1819
2021
Q4 		$159K Hold
4,300
– – ﹤0.01% 1794
2021
Q3 		$205K Buy
+4,300
New +$193K ﹤0.01% 1759
2021
Q1 		– Sell
-1,100
Closed -$47K – 2175
2020
Q4 		$47K Sell
1,100
-2,200
-67% -$149K ﹤0.01% 2000
2020
Q3 		$141K Hold
3,300
– – ﹤0.01% 1751
2020
Q2 		$154K Buy
+3,300
New +$114K ﹤0.01% 1695

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

STRS Ohio's ARCT Position: Q2 2025 in Review

STRS Ohio sold out of Arcturus Therapeutics (ARCT) in Q2 2025, closing a stake of 8,400 shares — an estimated $89K sold.

STRS Ohio first reported a position in ARCT in Q2 2020 and held it in 16 quarters. The position peaked at $794K in Q4 2023. 143 funds tracked by Wall St. Rank hold ARCT as of Q2 2025.

  • STRS Ohio reported no remaining Arcturus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • STRS Ohio sold 8,400 Arcturus Therapeutics shares in Q2 2025, an estimated $89K.
  • STRS Ohio first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 16 quarters.
  • STRS Ohio's Arcturus Therapeutics position peaked at $794K in Q4 2023.
  • 143 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.